The Current Ratio as of September 2024 (TTM) for Vallon Pharmaceuticals, Inc. (VLON) is 3.11

According to Vallon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.11. This represents a change of 40.63% compared to the average of 2.21 of the last 4 quarters.

Vallon Pharmaceuticals, Inc. (VLON) Historical Current Ratio (quarterly & annually)

How has VLON Current Ratio performed in the past?

The mean historical Current Ratio of Vallon Pharmaceuticals, Inc. over the last ten years is 2.20. The current 3.11 Current Ratio has changed 14.04% with respect to the historical average. Over the past ten years (40 quarters), VLON's Current Ratio was at its highest in in the September 2021 quarter at 7.55. The Current Ratio was at its lowest in in the September 2019 quarter at 0.

Vallon Pharmaceuticals, Inc. (VLON) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vallon Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vallon Pharmaceuticals, Inc. (VLON) Average Current Ratio

How has VLON Current Ratio performed in the past?

The current Current Ratio of Vallon Pharmaceuticals, Inc. (VLON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vallon Pharmaceuticals, Inc. (VLON) Current Ratio vs. Peers

How is VLON’s Current Ratio compared to its peers?

Vallon Pharmaceuticals, Inc.’s Current Ratio is less than Ikena Oncology, Inc. (18.22), less than Foghorn Therapeutics Inc. (5.69), less than Werewolf Therapeutics, Inc. (12.13), greater than Clene Inc. (0.99), less than Immunome, Inc. (7.12), less than Zura Bio Limited (12.57), less than Phio Pharmaceuticals Corp. (3.47), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than 180 Life Sciences Corp. (0.58), less than Cardio Diagnostics Holdings, Inc. (5.69), less than Palisade Bio, Inc. (4.31), less than Quoin Pharmaceuticals, Ltd. (3.35), greater than Revelation Biosciences, Inc. (1.10), less than Virax Biolabs Group Limited (25.94), less than Unicycive Therapeutics, Inc. (3.37), greater than ContraFect Corporation (0.53), greater than Allarity Therapeutics, Inc. (2.01), greater than CNS Pharmaceuticals, Inc. (0.31), greater than Windtree Therapeutics, Inc. (0.23), greater than Panbela Therapeutics, Inc. (0.05),

Build a custom stock screener for Vallon Pharmaceuticals, Inc. (VLON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vallon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vallon Pharmaceuticals, Inc. (VLON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vallon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.